Clinical Pharmacokinetics of the Nicotinic Channel Modulator Dexmecamylamine (TC-5214) in Subjects with Various Degrees of Renal Impairment
Crossref DOI link: https://doi.org/10.1007/s40261-014-0195-0
Published Online: 2014-04-24
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alverlind, Sofie
Barassin, Stéphane
Dalén, Per
Li, Yan
Toler, Steven
Eriksson, Hans
Tummala, Raj
Text and Data Mining valid from 2014-04-24